Medicine & Life Sciences
Multiple Sclerosis
100%
Tuberous Sclerosis
40%
Natalizumab
29%
Holoprosencephaly
26%
Therapeutics
24%
Cerebral Palsy
20%
Central Nervous System
18%
Neuromyelitis Optica
18%
T-Lymphocytes
18%
Child
17%
Central Nervous System Diseases
16%
Autoimmune Diseases of the Nervous System
16%
Relapsing-Remitting Multiple Sclerosis
16%
Autoimmune Experimental Encephalomyelitis
15%
Glioblastoma
14%
abobotulinumtoxinA
14%
Glatiramer Acetate
14%
Chronic Progressive Multiple Sclerosis
13%
B-Lymphocytes
13%
Hydroxymethylglutaryl-CoA Reductase Inhibitors
12%
ErbB Receptors
11%
Epilepsy
11%
epidermal growth factor receptor VIII
10%
Astrocytoma
10%
Brain
10%
Carbamazepine
10%
Autoimmunity
9%
Mutation
9%
Safety
9%
Everolimus
8%
Pharmaceutical Preparations
8%
siponimod
8%
Phenotype
8%
Cerebrospinal Fluid
8%
Progressive Multifocal Leukoencephalopathy
8%
Seizures
8%
Genes
8%
Angiomyolipoma
8%
Neoplasms
7%
Clinical Trials
7%
Glioma
7%
Interferon-beta
7%
Placebos
7%
Rituximab
7%
quinpramine
7%
Type A Botulinum Toxins
6%
Fingolimod Hydrochloride
6%
ocrelizumab
6%
Pediatrics
6%
Demyelinating Diseases
6%
Somatosensory Evoked Potentials
6%
Immunosuppressive Agents
6%
Acute Disseminated Encephalomyelitis
6%
Incidence
6%
Alemtuzumab
6%
Mitoxantrone
5%
Dimethyl Fumarate
5%
N-(5-(((5-(1,1-dimethylethyl)-2-oxazolyl)methyl)thio)-2-thiazolyl)-4-piperidinecarboxamide
5%
Injections
5%
Receptor-Interacting Protein Serine-Threonine Kinases
5%
teriflunomide
5%
Aquaporin 4
5%
Neuroimaging
5%
Interferons
5%
Oligodendrocyte-Myelin Glycoprotein
5%
4-dichlorobenzene
5%
Monoclonal Antibodies
5%
Recurrence
5%
Systematic Reviews
5%
Cladribine
5%
Autoimmune Diseases
5%